Early diagnosis and treatment of hepatocellular carcinoma

Best Practice and Research: Clinical Gastroenterology

Volumn 14, Issue 6, 2000, Pages 991-1008

  Llovet, Josep M ^a   Bruix, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Arterial embolization; Hepatocellular carcinoma; Liver transplantation; Percutaneous ethanol injection; Prognosis; Randomized controlled trials; Resection; Surveillance; Survival; Thermal ablation

Indexed keywords

ALCOHOL; ALPHA INTERFERON; CHOLIC ACID; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FLUTAMIDE; GELFOAM; GONADORELIN; IODINE 131; MITOMYCIN C; NILUTAMIDE; OCTREOTIDE; PLACEBO; TAMOXIFEN;

ARTICLE; ARTIFICIAL EMBOLISM; CANCER HORMONE THERAPY; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HOSPITAL ADMISSION; HUMAN; INJECTION PAIN; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; OUTCOMES RESEARCH; PERIODIC MEDICAL EXAMINATION; POLICY; RADIOFREQUENCY RADIATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0034504928     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2000.0143     Document Type: Article

References (65)

1. Rising incidence of hepatocellular carcinoma in the United States
2. Epidemiology of primary liver cancer
3. Treatment of hepatocellular carcinoma
4. Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis
5. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis
6. Hepatocellular carcinoma in Italian patients with cirrhosis
7. Prospective study of screening of hepatocellular carcinoma in Caucasian patients with cirrhosis
8. Screening for hepatocellular carcinoma in patients with child's a cirrhosis: An 8-year prospective study by ultrasound and alphafetoprotein
9. Efficacy of a surveillance program for early detection of hepatocellular carcinoma
10. Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection
11. Prognosis of hepatocellular carcinoma: The BCLC staging classification
12. Screening for hepatocellular carcinoma
13. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh Class A cirrhosis
14. Epidemiologic approach for cancer screening. Problems in design and analysis of trials
15. Hepatocellular carcinoma: Recent progress
16. Growth rates of asymptomatic hepatocellular carcinoma and its clinical implications
17. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis. A prospective study
18. Five-hundred life-saving interventions and their cost-effectiveness
19. Predicting the presence of significant portal hypertension and varices in compensated cirrhotic patients
20. Surgical resection versus transplantation for early hepatocellular carcinoma: Clues for the best strategy
21. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
22. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular cancer in Japan
23. Surgical resection of hepatocellular carcinoma in cirrhotic patients. Prognostic value of preoperative portal pressure
24. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma
25. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
26. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
27. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
28. Liver transplantation for hepatocellular carcinoma
29. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
30. Liver transplantation in the treatment of primary liver cancer
31. Liver transplantation for primary hepatocellular carcinoma: Tumor size and number determine outcome
32. Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis
33. Liver transplantation for treatment hepatocellular carcinoma: The TNM classification does not have prognostic power
34. Liver transplantation for hepatocellular carcinomas >5 cm diameter: Results of a multimodality protocol
35. Radical treatment of hepatocellular carcinoma during the waiting list for orthotopic liver transplantation: A cost-effectiveness analysis on an intention-to-treat basis
36. Tumor sizes determines the efficacy of percutaneous ethanol injection for treatment of small hepatocellular carcinoma
37. Long-term survival after ethanol injection for small hepatocellular carcinoma in 100 cirrhotic patients. Relevance of maintained success
38. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection
39. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: Analysis of 71 patients
40. Two-step treatment of large solitary hepatocellular carcinoma (HCC) by arterial embolization followed by ethanol injection
41. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection
42. Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions
43. Locoregional treatments for hepatocellular carcinoma
44. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma. Results of a randomized controlled trial in a single institution
45. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
46. A comparison of lipiodol chemo-embolization and conservative treatment for unresectable hepatocellular carcinoma
47. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial
48. Randomized trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma
49. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: Intra-arterial iodine-131-iodized oil versus medical support
50. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma
51. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma
52. Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients
53. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: A randomized, controlled trial
54. Tamoxifen in treatment of hepatocellular carcinoma: A randomized controlled trial
55. Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma
56. Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: Results of a European organization for research and treatment of Cancer. Multicentric double-blind trial
57. Recombinant interferon-alpha in inoperable hepatocellular carcinoma: A randomized controlled trial
58. Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
59. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial
60. Treatment of hepatocellular carcinoma with octreotide: A randomised controlled study
61. Diagnostic value and tolerance of Lipiodol-computed tomography for the detection of small hepatocellular carcinoma: Correlation with pathologic examination of explanted livers
62. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: Need for controlled trials
63. Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: A comparison with intravenous adriamycin
64. Benefit of transcatheter arterial embolization for ruptured hepatocellular carcinoma complicating liver cirrhosis
65. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials